Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis
Primary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregula...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/1/145 |
id |
doaj-55b27d113e5045e1a2482c102bb8ae06 |
---|---|
record_format |
Article |
spelling |
doaj-55b27d113e5045e1a2482c102bb8ae062020-11-24T21:06:33ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-01-0118114510.3390/ijms18010145ijms18010145Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary MyelofibrosisElisa Bianchi0Samantha Ruberti1Sebastiano Rontauroli2Paola Guglielmelli3Simona Salati4Chiara Rossi5Roberta Zini6Enrico Tagliafico7Alessandro Maria Vannucchi8Rossella Manfredini9Centre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCRIMM, Center for Research and Innovation for Myeloproliferative Neoplasms, AOU Careggi and Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyCenter for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, ItalyCRIMM, Center for Research and Innovation for Myeloproliferative Neoplasms, AOU Careggi and Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, ItalyCentre for Regenerative Medicine “Stefano Ferrari“, Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyPrimary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregulation of miR-34a-5p in PMF CD34+ hematopoietic progenitor cells (HPCs), in order to elucidate its role in PMF pathogenesis here we unravelled the effects of miR-34a-5p overexpression in HPCs. We showed that enforced expression of miR-34a-5p partially constrains proliferation and favours the megakaryocyte and monocyte/macrophage commitment of HPCs. Interestingly, we identified lymphoid enhancer-binding factor 1 (LEF1) and nuclear receptor subfamily 4, group A, member 2 (NR4A2) transcripts as miR-34a-5p-targets downregulated after miR-34a-5p overexpression in HPCs as well as in PMF CD34+ cells. Remarkably, the knockdown of NR4A2 in HPCs mimicked the antiproliferative effects of miR-34a-5p overexpression, while the silencing of LEF1 phenocopied the effects of miR-34a-5p overexpression on HPCs lineage choice, by favouring the megakaryocyte and monocyte/macrophage commitment. Collectively our data unravel the role of miR-34a-5p in HPCs fate decision and suggest that the increased expression of miR-34a-5p in PMF HPCs could be important for the skewing of megakaryopoiesis and the production of monocytes, that are key players in BM fibrosis in PMF patients.http://www.mdpi.com/1422-0067/18/1/145miR-34a-5pnuclear receptor subfamily 4, group A, member 2 (NR4A2)lymphoid enhancer-binding factor 1 (LEF1)MYBhematopoetic progenitor cellshematopoietic differentiationmegakaryopoiesisprimary myelofibrosismyeloproliferative neoplasmsmacrophage |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elisa Bianchi Samantha Ruberti Sebastiano Rontauroli Paola Guglielmelli Simona Salati Chiara Rossi Roberta Zini Enrico Tagliafico Alessandro Maria Vannucchi Rossella Manfredini |
spellingShingle |
Elisa Bianchi Samantha Ruberti Sebastiano Rontauroli Paola Guglielmelli Simona Salati Chiara Rossi Roberta Zini Enrico Tagliafico Alessandro Maria Vannucchi Rossella Manfredini Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis International Journal of Molecular Sciences miR-34a-5p nuclear receptor subfamily 4, group A, member 2 (NR4A2) lymphoid enhancer-binding factor 1 (LEF1) MYB hematopoetic progenitor cells hematopoietic differentiation megakaryopoiesis primary myelofibrosis myeloproliferative neoplasms macrophage |
author_facet |
Elisa Bianchi Samantha Ruberti Sebastiano Rontauroli Paola Guglielmelli Simona Salati Chiara Rossi Roberta Zini Enrico Tagliafico Alessandro Maria Vannucchi Rossella Manfredini |
author_sort |
Elisa Bianchi |
title |
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis |
title_short |
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis |
title_full |
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis |
title_fullStr |
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis |
title_full_unstemmed |
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis |
title_sort |
role of mir-34a-5p in hematopoietic progenitor cells proliferation and fate decision: novel insights into the pathogenesis of primary myelofibrosis |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2017-01-01 |
description |
Primary Myelofibrosis (PMF) is a chronic Philadelphia-negative myeloproliferative neoplasm characterized by a skewed megakaryopoiesis and an overproduction of proinflammatory and profibrotic mediators that lead to the development of bone marrow (BM) fibrosis. Since we recently uncovered the upregulation of miR-34a-5p in PMF CD34+ hematopoietic progenitor cells (HPCs), in order to elucidate its role in PMF pathogenesis here we unravelled the effects of miR-34a-5p overexpression in HPCs. We showed that enforced expression of miR-34a-5p partially constrains proliferation and favours the megakaryocyte and monocyte/macrophage commitment of HPCs. Interestingly, we identified lymphoid enhancer-binding factor 1 (LEF1) and nuclear receptor subfamily 4, group A, member 2 (NR4A2) transcripts as miR-34a-5p-targets downregulated after miR-34a-5p overexpression in HPCs as well as in PMF CD34+ cells. Remarkably, the knockdown of NR4A2 in HPCs mimicked the antiproliferative effects of miR-34a-5p overexpression, while the silencing of LEF1 phenocopied the effects of miR-34a-5p overexpression on HPCs lineage choice, by favouring the megakaryocyte and monocyte/macrophage commitment. Collectively our data unravel the role of miR-34a-5p in HPCs fate decision and suggest that the increased expression of miR-34a-5p in PMF HPCs could be important for the skewing of megakaryopoiesis and the production of monocytes, that are key players in BM fibrosis in PMF patients. |
topic |
miR-34a-5p nuclear receptor subfamily 4, group A, member 2 (NR4A2) lymphoid enhancer-binding factor 1 (LEF1) MYB hematopoetic progenitor cells hematopoietic differentiation megakaryopoiesis primary myelofibrosis myeloproliferative neoplasms macrophage |
url |
http://www.mdpi.com/1422-0067/18/1/145 |
work_keys_str_mv |
AT elisabianchi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT samantharuberti roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT sebastianorontauroli roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT paolaguglielmelli roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT simonasalati roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT chiararossi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT robertazini roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT enricotagliafico roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT alessandromariavannucchi roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis AT rossellamanfredini roleofmir34a5pinhematopoieticprogenitorcellsproliferationandfatedecisionnovelinsightsintothepathogenesisofprimarymyelofibrosis |
_version_ |
1716765565732782080 |